{"id":51259,"date":"2022-11-25T17:02:09","date_gmt":"2022-11-25T16:02:09","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/europe-diagnostic-labs-market-report-2022-increasing-adoption-of-automated-platforms-presents-opportunities-researchandmarkets-com\/"},"modified":"2022-11-25T17:02:09","modified_gmt":"2022-11-25T16:02:09","slug":"europe-diagnostic-labs-market-report-2022-increasing-adoption-of-automated-platforms-presents-opportunities-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/europe-diagnostic-labs-market-report-2022-increasing-adoption-of-automated-platforms-presents-opportunities-researchandmarkets-com\/","title":{"rendered":"Europe Diagnostic Labs Market Report 2022: Increasing Adoption of Automated Platforms Presents Opportunities – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Europe Diagnostic Labs Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – By Lab Type, Testing Services and Revenue Source”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe Europe diagnostic labs market is expected to grow from US$ 88.31 billion in 2022 to US$ 139.27 billion by 2028. It is estimated to grow at a CAGR of 7.9% from 2022 to 2028.\n<\/p>\n

\nPoint-of-care testing (POCT) has become critical to patient-centric healthcare due to the rapid diagnostic results required for accurate and faster treatment decisions. A shift from centralized point-of-care testing to decentralized testing for chronic and infectious patients has resulted in convenient patient access to these diagnostics.\n<\/p>\n

\nThe current trend in Point-of-Care Diagnostics (POCD) is strongly tipping toward mobile healthcare (mH) smart devices, which could revolutionize personalized healthcare monitoring and management, paving the way for next-generation POCT. POCT can significantly improve infectious disease management, particularly in developing countries where access to timely medical care is challenging, and healthcare infrastructure is outdated and sparse.\n<\/p>\n

\nIn addition, technological developments in diagnostic kits have resulted in fewer manual errors, thus, becoming a prominent driver of the diagnostic labs market. The demand for high-quality point-of-care diagnostic kits is increasing rapidly with the rising prevalence of acute and chronic diseases. The extent of cirrhosis due to HBV varies across the region. Regionally, HBV is associated with one-third of deaths from HCC. Considering the above statistics, the demand for diagnostic products among patients is anticipated to increase in the coming years. The high prevalence of HIV is expected to boost the demand for point-of-care diagnostics and further accelerate the growth of the diagnostic labs market during the forecast period.\n<\/p>\n

\nWith new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe diagnostic labs market growth at a notable CAGR during the forecast period.\n<\/p>\n

\nEurope Diagnostic Labs Market Segmentation<\/strong>\n<\/p>\n

\nThe Europe diagnostic labs market is segmented on the basis of lab type, testing services, revenue source, and country.\n<\/p>\n